Free Trial

Xtant Medical (XTNT) Insider Trading & Ownership

Xtant Medical logo
$0.57 -0.02 (-3.32%)
As of 04:10 PM Eastern

Xtant Medical (NYSEAMERICAN:XTNT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.70%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$1.09 M
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$59,690.53
Get XTNT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xtant Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

XTNT Insider Buying and Selling by Quarter

Xtant Medical Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/18/2023Scott C NeilsCFOSell8,673$0.61$5,290.53  
10/18/2022Sean E BrowneCEOSell80,000$0.68$54,400.00  
10/7/2022Stavros G VizirgianakisDirectorBuy2,264,861$0.48$1,087,133.28  
(Data available from 1/1/2013 forward)

XTNT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Xtant Medical includes Scott C Neils, Sean E Browne, and Stavros G Vizirgianakis. Learn more on insiders at XTNT.

9.70% of Xtant Medical stock is owned by insiders. Learn more on XTNT's insider holdings.

Xtant Medical Key Executives

  • Mr. Sean E. Browne (Age 58)
    President, CEO & Director
    Compensation: $1.29M
  • Mr. Mark A. Schallenberger (Age 38)
    Chief Operations Officer
    Compensation: $778.42k
  • Mr. Kevin D. Brandt (Age 58)
    Senior VP & Chief Commercial Officer
    Compensation: $658.03k
  • Mr. Scott C. Neils (Age 40)
    Chief Financial Officer
    Compensation: $517.86k
  • Ms. Catherine Lundy
    Vice President of Human Resources


This page (NYSEAMERICAN:XTNT) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners